Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sankar D Navaneethan

Showing results (141-150 of 281) with videos related to

Pageof 29
Sort By:
The Cochrane Database of Systematic Reviews|February 18, 2011
Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsSankar D Navaneethan, Suetonia C Palmer, Mariacristina Vecchio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2017
Diabetes Control and the Risks of ESRD and Mortality in Patients With CKDSankar D Navaneethan, Jesse D Schold, Stacey E Jolly, et al.
Southern Medical Journal|May 23, 2006
Hospitalist physicians as educators in a community hospital: the trainee's viewSankar D Navaneethan, Amit Nautiyal, Khalid Abdel-Gadir, et al.
Annals of Internal Medicine|August 23, 2012
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysisSuetonia C Palmer, Jonathan C Craig, Sankar D Navaneethan, et al.
Kidney Medicine|June 17, 2026
The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC)Marcelle Tuttle, Hocine Tighiouart, Tatsufumi Oka, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsSankar D Navaneethan, Vlado Perkovic, David W Johnson, et al.
The Cochrane Database of Systematic Reviews|October 27, 2020
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney diseaseEdmund Ym Chung, Marinella Ruospo, Patrizia Natale, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2015
Renal resistive index and mortality in chronic kidney diseaseClarisse Toledo, George Thomas, Jesse D Schold, et al.
Kidney International Reports|May 14, 2019
Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With ESKD Initiating DialysisSamaya Anumudu, Medha Airy, Kevin F Erickson, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
HMG CoA reductase inhibitors (statins) for dialysis patientsSankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, et al.
Pageof 29

Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
The Cochrane Database of Systematic Reviews|February 18, 2011
Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsSankar D Navaneethan, Suetonia C Palmer, Mariacristina Vecchio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 16, 2017
Diabetes Control and the Risks of ESRD and Mortality in Patients With CKDSankar D Navaneethan, Jesse D Schold, Stacey E Jolly, et al.
Southern Medical Journal|May 23, 2006
Hospitalist physicians as educators in a community hospital: the trainee's viewSankar D Navaneethan, Amit Nautiyal, Khalid Abdel-Gadir, et al.
Annals of Internal Medicine|August 23, 2012
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysisSuetonia C Palmer, Jonathan C Craig, Sankar D Navaneethan, et al.
Kidney Medicine|June 17, 2026
The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC)Marcelle Tuttle, Hocine Tighiouart, Tatsufumi Oka, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsSankar D Navaneethan, Vlado Perkovic, David W Johnson, et al.
The Cochrane Database of Systematic Reviews|October 27, 2020
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney diseaseEdmund Ym Chung, Marinella Ruospo, Patrizia Natale, et al.
Hypertension (Dallas, Tex. : 1979)|June 17, 2015
Renal resistive index and mortality in chronic kidney diseaseClarisse Toledo, George Thomas, Jesse D Schold, et al.
Kidney International Reports|May 14, 2019
Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With ESKD Initiating DialysisSamaya Anumudu, Medha Airy, Kevin F Erickson, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
HMG CoA reductase inhibitors (statins) for dialysis patientsSankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, et al.
Pageof 29